1. Coutelle, C., Themis, M., Waddington, S. N., Buckley, S. M., Gregory, L. G., Nivsarkar, M. S., David, A. L., Peebles, D., Weisz, B., & Rodeck, C. (2005). Gene therapy progress and prospects: Fetal gene therapy – First proofs of concept – Some adverse events. Gene Therapy, 12, 1601–1607.
2. Encyclopedia of Genetics, Genomics, Proteomics and Informatics. (2014). Gene therapy. http://www.springerreference.com/docs/html/chapterdbid/97017.html. Accessed 25 Feb 2014.
3. Guo, J., & Xin, H. (2006). Chinese gene therapy: Splicing out the West? Science, 314, 1232–1235.
4. Hacein-Bey-Abina, S., Von Kalle, C., Schmidt, M., McCormack, M. P., Wulffraat, N., Leboulch, P., Lim, A., Osborne, C. S., Pawliuk, R., Morillon, E., Sorensen, R., Forster, A., Fraser, P., Cohen, J. I., de Saint Basile, G., Alexander, A., Wintergerst, U., Frebourg, T., Aurias, A., Stoppa-Lyonnet, D., Romana, S., Radford-Weiss, I., Gross, F., Valensi, F., Delabesse, E., Macintyre, E., Sigaux, F., Soulier, J., Leiva, L. E., Wissler, M., Prinz, C., Rabbitts, T. H., LeDeist, F., Fischer, A., & Cavazzana-Calvo, M. (2003). LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1. Science, 17(5644), 415–419.
5. Isasi, R. M., Knoppers, B. M., & Nguyen, M. T. (2006). National Regulatory Frameworks regarding Human Genetic Modification Technologies (Somatic and Germline Modification): A report for the genetics and public policy center. http://www.dnapolicy.org/pdf/geneticModification.pdf. Accessed 25 Feb 2014.